a contest disseminate knowledge about the 100 year history of immunotherapy
-stand Stallergenes at the International Symposium of allergy food. 100 years of immunotherapy of the Spanish society of Allergology and Clinical Immunology (SEAIC) will host the interactive quiz of questions and answers allergy Game ” on scientific issues related to allergen immunotherapy
– the objective of this activity is to spread knowledge about the treatment of Allergy and involve practitioners in the history of immunotherapy
– may participate any healthcare professional close to the stand and to respond, through a command of televoting, the five questions that appear on screen
Barcelona, 2011-October spread knowledge about the treatment of Allergy and involve practitioners in the history of immunotherapy It is the goal of allergy Game ”, contest organized by Stallergenes. This company in the international food allergy Symposium’s stand. 100 years of immunotherapy of the Spanish society of Allergology and Clinical Immunology (SEAIC), which will take place in Barcelona from 10 to 12 November next, will host an interactive quiz of questions of a scientific nature on immunotherapy and Oralair ®, the first treatment precoestacional of sublingual immunotherapy in pills against allergic rhinitis.
All medical practitioners who come to the stand of Stallergenes may participate in this game; through a command of televoting contestants answer five questions that comprises the game and they will appear on screen. To do this, they will have three possible answers, which will only be one correct.
Each participant may enter once a day during the three days of duration of the Symposium.
Get better score who correctly answer as many questions in the shortest possible time. The system will record the time taken to respond. In the event of a tie, it warranted the less time taken to answer the first three questions.
Only for participating each doctor you will receive a gift and the five best contestants in the ranking at the end of each day will be presented with a symbolic prize and recognized as winners of the contest.
About Stallergenes
Stallergenes S.A. is a biopharmaceutical company international, a leader in the manufacture and innovation of allergen immunotherapy treatments. Stallergenes sells its products to prevent and control the allergic disease in 50 countries by more than 10 subsidiaries in Europe and 40 agreements of distribution and collaboration around the world.
The factory of Stallergenes in Antony (Ãle-de-France) is the major centre of production of allergen preparations specially for a patient (APEP) in the world, making it more than 150 different allergens to treat annually some 500,000 patients.
Around 20% of the annual turnover of pharmaceutical company, it is intended for research and development. In 2010 Stallergenes invoiced a volume of 216 million euros.
Stallergenes Ibérica S.A. is the subsidiary of Stallergenes S.A. Spain Stallergenes Ibérica s.a. owns one portfolio of products for the treatment of 95% of patients affected by respiratory allergic diseases and it has been, since its implementation in Spanish territory for 11 years, by a strong work of research into new products.
